aspsirna0245 details

''''
ASPsiRNA information siRNA Id:aspsirna0245
siRNA Name: LRRK2 P5
Mismatch information Wild siRNA (As strand 3'->5'):UCUAACGACUGAUGCCGUA
ASP-siRNA (As strand 3'->5'):UCUAACGACUGAUGUCGUA
Mismatch position in siRNA: U5C
Gene Information Gene Name Leucine rich repeat kinase 2 (LRRK2) Gene
Target Sequence (5'->3'):UUGCAAAGAUUGCUGACUACGGCAUUGCUCAGUACUGC
Wild allele (5'->3'):AGAUUGCUGACUACGGCAU
Mutant allele (5'->3'):AGAUUGCUGACUACAGCAU
Position of siRNA on target gene: 6162-6180
Respective Gene/Protein Resources GenBank Accession:NM_198578.3
Cytogenic location:12q12
Chromosomal coordinates:12:40,618,812-40,763,086
UniProt ID:Q5S007
HUGO ID:18618
Reference SNp(RefSNP): rs34637584
Disease/Mutation information Target Mutation: c.6055G>A,p.Gly2019Ser
Matation type/variant: Single nucleotide variant/Missense variant
Mutation at gene level: NG_011709.1:g.120390G>A
Pathogenic status of mutation: Pathogenic
Disease:Parkinsons disease (PD)
Clinical Resources ClinVar ID:1940
KEGG disease ID:H00057
OMIM ID: 168600
COSMIC: LRRK2
DECIPHER: LRRK2
GeneTests: LRRK2
ASP siRNA details Mutant allele (5'->3'): AGAUUGCUGACUACAGCAU
ASP-siRNA (As strand 3'->5'):UCUAACGACUGAUGUCGUA
Percentage efficacy of ASP-siRNA for mutant allele:13
Wild allele (5'->3'): AGAUUGCUGACUACGGCAU
ASP-siRNA (As strand 3'->5'):UCUAACGACUGAUGUCGUA
Percentage efficacy of ASP-siRNA for wild allele:88
Relative difference:-75
Wild siRNA details Wild allele (5'->3'): AGAUUGCUGACUACGGCAU
Wild siRNA (As strand 3'->5'):UCUAACGACUGAUGCCGUA
Percentage efficacy of wild siRNA for wild allele:High efficacy
Wild allele (5'->3'): AGAUUGCUGACUACGGCAU
ASP-siRNA (As strand 3'->5'):UCUAACGACUGAUGUCGUA
Percentage efficacy of Wild sirna for mutant allele:Moderate efficacy
Relative difference :Poor discrimination
General information Mismatch incorporated in siRNA/Target:siRNA
Cell-line used: HEK293
Experimental technique used: Dual luciferase reporter assay
Transfection method: Lipofectamine 2000
siRNA expression method: Sigma Genosys
Post-transfection duration: 48 hours
Concentration used:50nM
Reference:22031823
Delivery method:shRNA expression vector delivery
Article title:Identification of allele-specific RNAi effectors targeting genetic forms of Parkinson's disease.
Authors:Sibley CR, Wood MJ.
Journal Reference:PLoS One. 2011;6(10):e26194. doi: 10.1371/journal.pone.0026194. Epub 2011 Oct 21.